Lipella Pharmaceuticals Inc.
LIPO· Unspecified
LIPOLipella Pharmaceuticals Inc.
Filed Nov 14, 2024 · 10-Q · 45 days after period end · 0001753926-24-001927
| Metric | Q3 2024 | Q3 2023 | Q3 2022 |
|---|---|---|---|
| Revenue | $80.38K | $104.05K | $0.00 |
| Net Income | -$1.44M | -$1.32M | -$713.79K |
| EPS Diluted | -$1.29 | -$1.84 | -$0.17 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Lipella Pharmaceuticals Inc. · CIK 1347242 · Engraved from SEC EDGAR
ended Sep 30, 2024 · filed Nov 14, 2024 · 45 d after period end
